# Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort

## TL;DR

This study finds that a family history of cancer is linked to certain patient traits in gastroesophageal cancer but not to prognosis or tumor features.

## Contribution

The study provides new insights into the association of family history with patient characteristics in gastroesophageal cancer using a large European cohort.

## Key findings

- A positive family history correlates with female gender, earlier cancer stages, higher BMI, and alcohol consumption.
- Family history of gastroesophageal cancer is associated with higher age at diagnosis and stomach cancer.
- No significant association was found between family history and overall survival or histopathological features.

## Abstract

The role of the family history in the development and prognosis of gastroesophageal cancer is a controversially discussed topic as appropriate data from western cohorts are lacking. This study aims to explore its associations with disease and outcome parameters in a large European cohort.

We retrospectively analyzed self-reported family history in patients with gastroesophageal cancer treated between 1 January 1990 and 31 December 2021 at the Medical University of Vienna. Association analyses with patient characteristics, tumor characteristics, symptoms and overall survival (OS) were performed.

In our cohort of 1762 gastroesophageal cancer patients, 592 (34%) reported a positive family history of cancer (159, 9%, gastroesophageal cancer). No associations were found with histopathological parameters or initial symptoms; however, a positive family history correlated with female gender (cancer in general: p = 0.011; gastroesophageal cancer: p = 0.015). Family history of cancer in general was associated with earlier cancer stages (p = 0.04), higher BMI (p = 0.005), and alcohol consumption (p = 0.010), while a positive history for gastroesophageal cancer was associated with higher age at diagnosis (p = 0.002) and stomach cancer (p = 0.002). There was no statistically significant association of positive family history with OS (p = 0.1, p = 0.45), also not in subgroups for histology (adeno and squamous cell), number of family members and degree of relative.

Our results emphasize that a positive family history is neither statistically significantly associated with prognosis nor with specific histopathological features in patients with gastroesophageal cancer. Yet, associations with distinct patient characteristics and positive family history indicate that specific subgroups might profit from endoscopic surveillance. Prospective studies are warranted to investigate these findings further.

The online version of this article (10.1007/s00508-024-02432-3) contains supplementary material, which is available to authorized users.